Find A Clinical Trial
Disease Type: Sarcoma
Trial ID
INBRX-209
Sponsor ID
Inhibrx
A Randomized, Blinded, Placebo-Controlled, Phase 2 Study of INBRX-109 in Unrsectable or Metastatic Conventional Chondrosarcoma
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
2 Locations
Trial ID
TTI-621-03
Sponsor ID
Trillium Therapeutics
A Phase 1/2 Study of TTI-621 in Combination with Doxorubacin in Patients with Unresectable or Metastatic High-Grade Leiomyosarcoma
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
SALA-002-EW16
Sponsor ID
Salarius Pharmaceuticals
A Phase I Trial of LSD1 Inhibitor Seclidemstat (SP-2577) with and without Topetecan and Cyclophosphamide in Patients with Relapsed or Refractory Ewing Sarcoma and Select Sarcomas
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location